ImmunityBio, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
ImmunityBio, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q3 2024.
  • ImmunityBio, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 696M shares, a 39.6% increase year-over-year.
  • ImmunityBio, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 509M shares, a 27.2% increase from 2022.
  • ImmunityBio, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 400M shares, a 2.74% increase from 2021.
  • ImmunityBio, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 389M shares, a 3.23% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 696M +198M +39.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 687M +249M +57% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 673M +244M +57.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 509M +109M +27.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 498M +98.3M +24.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 437M +39.5M +9.92% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 428M +30.5M +7.67% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 400M +10.7M +2.74% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 400M +8.21M +2.09% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 398M +13.2M +3.42% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 398M +15.1M +3.96% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 389M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-19
Q3 2021 392M +10.1M +2.64% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 385M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 383M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 382M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.